Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|April 1, 2008
Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signallingLaila Al Shaer, Elisabeth Walsby, Amanda Gilkes, et al.Blood|January 26, 2011
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivoTakashi Sato, Xiaochuan Yang, Steven Knapper, et al.Haematologica|February 28, 2016
Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 TrialAlan Burnett, Jamie Cavenagh, Nigel Russell, et al.British Journal of Haematology|May 7, 2021
A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trialMike Dennis, Alan Burnett, Robert Hills, et al.Leukemia Research|October 5, 2002
Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemiaPaul Baines, Steve Austin, Janet Fisher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trialsClaire H Seedhouse, Martin Grundy, Paul White, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2006
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter studyNorbert Vey, Andre Bosly, Agnes Guerci, et al.British Journal of Haematology|April 9, 2005
Del (9q) AML: clinical and cytological characteristics and prognostic implicationsAndrew Peniket, James Wainscoat, Lucy Side, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working PartyPriya Virappane, Rosemary Gale, Robert Hills, et al.Nature Reviews. Disease Primers|May 10, 2016
Acute myeloid leukaemiaAsim Khwaja, Magnus Bjorkholm, Rosemary E Gale, et al.Pageof 4